Delaware (State or Other Jurisdiction of Incorporation) |
000-51541 (Commission File Number) |
77-0552594 (I.R.S. Employer Identification No.) |
301 Penobscot Drive Redwood City, California (Address of principal executive offices) |
94063 (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c)) |
ITEM 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
(b) | On April 14, 2008, Michael D. Goldberg notified Genomic Health, Inc., a Delaware corporation (the Company), that he was resigning from the Board of Directors effective as of the Companys 2008 Annual Meeting of Stockholders on May 21, 2008. Mr. Goldberg has been a member of the Companys Board of Directors since 2001. |
2
GENOMIC HEALTH, INC. |
||||
By: | /s/ G. Bradley Cole | |||
G. Bradley Cole | ||||
Executive Vice President, Operations, and Chief Financial Officer |
||||
3